| Disaggregation of Revenue |
The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 28, 2025 | | Three Months Ended June 29, 2024 | Business (in millions) | United States | International | Total | | United States | International | Total | | Diagnostics: | | | | | | | | | Cytology & Perinatal | $ | 75.8 | | $ | 45.6 | | $ | 121.4 | | | $ | 73.3 | | $ | 48.9 | | $ | 122.2 | | | Molecular Diagnostics | 254.4 | | 66.1 | | 320.5 | | | 245.4 | | 65.3 | | 310.7 | | | Blood Screening | 7.0 | | — | | 7.0 | | | 7.9 | | — | | 7.9 | | | Total | $ | 337.2 | | $ | 111.7 | | $ | 448.9 | | | $ | 326.6 | | $ | 114.2 | | $ | 440.8 | | | | | | | | | | | | Breast Health: | | | | | | | | | Breast Imaging | $ | 204.2 | | $ | 60.5 | | $ | 264.7 | | | $ | 240.4 | | $ | 68.8 | | $ | 309.2 | | | Interventional Breast Solutions | 75.4 | | 25.1 | | 100.5 | | | 60.1 | | 15.7 | | 75.8 | | | | | | | | | | | | Total | $ | 279.6 | | $ | 85.6 | | $ | 365.2 | | | $ | 300.5 | | $ | 84.5 | | $ | 385.0 | | | | | | | | | | | | GYN Surgical | $ | 126.2 | | $ | 52.2 | | $ | 178.4 | | | $ | 125.8 | | $ | 40.8 | | $ | 166.6 | | | | | | | | | | | Skeletal Health | $ | 17.7 | | $ | 13.6 | | $ | 31.3 | | | $ | 12.4 | | $ | 6.6 | | $ | 19.0 | | | | $ | 760.7 | | $ | 263.1 | | $ | 1,023.8 | | | $ | 765.3 | | $ | 246.1 | | $ | 1,011.4 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | Nine Months Ended June 28, 2025 | | Nine Months Ended June 29, 2024 | Business (in millions) | United States | International | Total | | United States | International | Total | | Diagnostics: | | | | | | | | | Cytology & Perinatal | $ | 222.9 | | $ | 142.5 | | $ | 365.4 | | | $ | 213.7 | | $ | 149.0 | | $ | 362.7 | | | Molecular Diagnostics | 775.6 | | 211.8 | | 987.4 | | | 748.4 | | 204.8 | | 953.2 | | | Blood Screening | 20.3 | | — | | 20.3 | | | 22.8 | | — | | 22.8 | | | Total | $ | 1,018.8 | | $ | 354.3 | | $ | 1,373.1 | | | $ | 984.9 | | $ | 353.8 | | $ | 1,338.7 | | | | | | | | | | | | Breast Health: | | | | | | | | | Breast Imaging | $ | 629.4 | | $ | 188.7 | | $ | 818.1 | | | $ | 703.7 | | $ | 213.6 | | $ | 917.3 | | | Interventional Breast Solutions | 203.8 | | 68.5 | | 272.3 | | | 181.6 | | 48.4 | | 230.0 | | | | | | | | | | | | Total | $ | 833.2 | | $ | 257.2 | | $ | 1,090.4 | | | $ | 885.3 | | $ | 262.0 | | $ | 1,147.3 | | | | | | | | | | | | GYN Surgical | $ | 365.1 | | $ | 142.2 | | $ | 507.3 | | | $ | 366.6 | | $ | 118.2 | | $ | 484.8 | | | | | | | | | | | Skeletal Health | $ | 46.5 | | $ | 33.6 | | $ | 80.1 | | | $ | 41.6 | | $ | 29.9 | | $ | 71.5 | | | | $ | 2,263.6 | | $ | 787.3 | | $ | 3,050.9 | | | $ | 2,278.4 | | $ | 763.9 | | $ | 3,042.3 | |
| | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | Geographic Regions (in millions) | | June 28, 2025 | June 29, 2024 | | June 28, 2025 | June 29, 2024 | | United States | | $ | 760.7 | | $ | 765.3 | | | $ | 2,263.6 | | $ | 2,278.4 | | | Europe | | 148.1 | | 127.9 | | | 443.5 | | 407.7 | | | Asia-Pacific | | 60.3 | | 65.0 | | | 179.7 | | 193.2 | | | Rest of World | | 54.7 | | 53.2 | | | 164.1 | | 163.0 | | | | $ | 1,023.8 | | $ | 1,011.4 | | | $ | 3,050.9 | | $ | 3,042.3 | |
The following table provides revenue recognized by source:
| | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | Revenue by type (in millions) | | June 28, 2025 | June 29, 2024 | | June 28, 2025 | June 29, 2024 | | Disposables | | $ | 658.4 | | $ | 623.2 | | | $ | 1,959.0 | | $ | 1,871.0 | | | Capital equipment, components and software | | 152.0 | | 188.0 | | | 462.0 | | 596.2 | | | Service | | 208.8 | | 196.8 | | | 615.3 | | 560.6 | | | Other | | 4.6 | | 3.4 | | | 14.6 | | 14.5 | | | | $ | 1,023.8 | | $ | 1,011.4 | | | $ | 3,050.9 | | $ | 3,042.3 | |
|